Zurich Cantonal Bank’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $415K | Sell |
29,565
-132
| -0.4% | -$1.85K | ﹤0.01% | 1770 |
|
|
2025
Q1 | $464K | Buy |
29,697
+917
| +3% | +$14.3K | ﹤0.01% | 1642 |
|
|
2024
Q4 | $401K | Buy |
28,780
+10,018
| +53% | +$140K | ﹤0.01% | 1766 |
|
|
2024
Q3 | $174K | Hold |
18,762
| – | – | ﹤0.01% | 2183 |
|
|
2024
Q2 | $174K | Buy |
+18,762
| New | +$174K | ﹤0.01% | 2106 |
|
|
2023
Q4 | – | Sell |
-6,060
| Closed | -$32.2K | – | 2731 |
|
|
2023
Q3 | $32.2K | Sell |
6,060
-1
| -0% | -$5 | ﹤0.01% | 2667 |
|
|
2023
Q2 | $57.8K | Hold |
6,061
| – | – | ﹤0.01% | 2565 |
|
|
2023
Q1 | $66.7K | Sell |
6,061
-965
| -14% | -$10.6K | ﹤0.01% | 2501 |
|
|
2022
Q4 | $104K | Buy |
7,026
+1,134
| +19% | +$16.8K | ﹤0.01% | 2241 |
|
|
2022
Q3 | $113K | Buy |
5,892
+4,530
| +333% | +$86.9K | ﹤0.01% | 2116 |
|
|
2022
Q2 | $29K | Sell |
1,362
-132
| -9% | -$2.81K | ﹤0.01% | 2730 |
|
|
2022
Q1 | $29K | Buy |
+1,494
| New | +$29K | ﹤0.01% | 2612 |
|